CORTICOSTEROID BIOGENESIS, METABOLISM, & MODE OF ACTION
CORTICOSTEROID BIOGENESIS, METABOLISM, & MODE OF ACTION
批准号:
3230695
负责人:
STANLEY ULICK
金额:
$10.75万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-04-01 至 1988-03-31
关键词:
adenoma adrenal hyperplasia aldosterone angiotensin /renin /aldosterone hypertension autosomal dominant trait cholesterol corticosteroids corticosterone cortisol dexamethasone enzyme substrate hormone inhibitor hormone regulation /control mechanism human tissue hyperadrenalism inborn metabolism disorder mineralocorticoids orphan disease /drug oxidoreductase steroid hormone biosynthesis steroid hormone metabolism urinalysis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Corticosteroid biogenesis will be examined at several points along the
pathway to the final hormonal products, cortisol and aldosterone. the
early portion of the pathway will be examined at the point of cleavage of
the side-chain of cholesterol by establishing an animal model of the defect
at this locus and the determination of the mechanism of deficiency of
side-chain cleavage activity. Evidence will also be sought to confirm the
hypothesis that a reversible block in cholesterol side-chain desmolase
occurs naturally in the human fetus. The consequences of 21-hydroxylase
deficiency on the synthesis of naturally occurring mineralocorticoid
antagonist will be investigated as well as the nature of the defect in
aldosterone biosynthesis in this inborn error. In the case of the distal
aldosterone biosynthetic defect between corticosterone and aldosterone, the
mechanism by which adult patients with the Type II defect adjusts to
aldosterone deficiency will be examined. The steroid pattern will also be
examined in another group of patients to establish the existence of a Type
I defect involving this portion of the aldosterone biosynthetic pathway.
Studies will continue on the 11 Beta-hydroxyoxidoreductase equilibrium
shift observed in a juvenile form of low-renin mineralocorticoid
hypertension. In addition, the steroid pattern will be examined in a
biochemical variant of this disorder in which the syndrome is reversed by
dexamethasone. Studies on the significance of our newly discovered
cortisol 18-oxidase pathway will be conducted. The usefulness of this
pathway in the differential diagnosis of aldosteronoma compared to
bilateral adrenocortical hyperplasia will be examined. Studies will also
be carried out on the mechanism of the predominance of this pathway in
autosomaldominant ACTH-dependent hyperaldosteronism. Confirmation will
also be sought for the preliminary finding that the final product of the
cortisol 18-oxidase pathway is 17Alpha-hydroxyaldosterone. The biological
significance of the latter steroid and its contribution to the clinical
picture of the disorders in which it is overproduced will be studied.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORTICOSTEROID BIOGENESIS, METABOLISM, & MODE OF ACTION
-
批准号:3152467
-
项目类别:
-
资助金额:$11.22万
-
财政年份:1983
-
负责人:STANLEY ULICK
-
依托单位:
CORTICOSTEROID BIOGENESIS, METABOLISM, & MODE OF ACTION
-
批准号:3230696
-
项目类别:
-
资助金额:$11.96万
-
财政年份:1983
-
负责人:STANLEY ULICK
-
依托单位:
海外基金